Search

22 Feb 2023: We are delighted to announce that Cambridge Enterprise and the Parkwalk Opportunities Fund and have completed an investment in PredictImmune Limited, a...

23 Feb 2023: Drug discovery company Storm Therapeutics announces the appointment of Keith Blundy as CEO and Tim Edwards as Chairman.

22 Feb 2023: Nyobolt—a cutting-edge battery company that is defining a new category of ultra-high power technology—has secured $10 million in Series A funding. ... The funding will enable Nyobolt to expand globally, building new facilities and growing its

22 Feb 2023: Jonathan Milner and other local angels have formed a syndicate with the Enterprise Fund to support this exciting new venture. ... The scheme allows individuals to invest in new companies while benefitting from generous tax incentives.

22 Feb 2023: 12 December 2013. Definigen raises £1.3m in funding. Share:. Cambridge spin-out Definigen has completed a new funding round worth £1.3 million, led by Cambridge Enterprise. ... Definigen will use the funding to accelerate production and introduce new

23 Feb 2023: Sphere Fluidics’ technology enables the study of the mechanism of cancer cell resistance to chemotherapy, the generation of new enzymes and identification of novel microbial strains.

23 Feb 2023: months are just some of the technologies being developed by new companies based on Cambridge research, with funding support from the University seed funds. ... The companies receiving either new or follow-on support included Aqdot, CamSemi, DefiniGEN,

22 Feb 2023: He added: “We would also like to welcome our new CEO, Dr Fedja Bobanovic, who has an exceptional track record of generating growth in life sciences businesses.“. ... Somu Subramanian, new board member and founding partner of New Science Ventures,

22 Feb 2023: 17 March 2020. DIOSynVax works towards vaccine against COVID-19. Share:. It is hard now to conceive that two months ago few people had heard of the new coronavirus. ... In the past few years, Heeney has won significant funding and investment from the

23 Nov 2023: to share best practice and open up new avenues of agri-tech research.

22 Feb 2023: Current investors New Science Ventures and Syncona Partners. In conjunction with the fundraising, Tom Hulme, GV general partner, will join CEGX’s board of directors and co-founder Dr Bobby ... New CEO Dr Geoff Smith joins CEGX from Illumina, where he

23 Feb 2023: This year we were pleased to sponsor two new prizes: the Cambridge Enterprise Academic Entrepreneur of the Year Award and the Cambridge Enterprise Lifetime Achievement Award. ... In addition to the two new awards sponsored by Cambridge Enterprise, we

23 Feb 2023: Share:. Evotec AG today announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs for oncology and other therapeutic areas. ... STORM is the only company harnessing the power of RNA

23 Feb 2023: The second prize of £10,000 went to NeutroCheck, which is developing a new medical device that will deliver more efficient healthcare for cancer patients worldwide. ... an entirely new class of bio-material; and Textile Two Dimensional, which is

22 Feb 2023: During this period, 400 new knowledge and technology transfer transactions were completed, bringing the portfolio to over 700 active equity, consultancy and licence agreements under management.

15 Nov 2023: The company’s OpTiMus platform can sidestep this issue by creating a near unlimited database of optimal TCRs, which can act as building blocks for new therapies. ... We are proud to be alongside Allan and the team as they pioneer a new era in cancer

21 Mar 2023: It is the result of a culture of excellence, underpinned by a depth and breadth of teaching, research and innovation that connects the discovery of new knowledge with the expertise to

22 Feb 2023: months. “We help businesses gain a comprehensive understanding of risk, particularly in new and emerging markets, by leveraging the observation power of the internet”, says Hartley. ... The company has also added a new non-executive chairman to the

22 Feb 2023: 8power Limited, Cambridge start up developing smart sensors for industrial applications, has won the 7th CW Discovering Startups Competition.

22 Feb 2023: The new investment will enable Nu Quantum to develop its technology into full prototypes over the next 18 months.